Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Subscribe and saveSummer Special! Upgrade here at £1.99/m (50% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Celltrion
Biotech
Topics

Advertisement

Advertisement

Celltrion

Share

Top Latest Popular

Thursday

Celltrion’s Steqeyma reaches 16.2% share of US ustekinumab market: IQVIA Korea Biomedical Review 01:46 Thu, 03 Sep

In the last month

Celltrion’s SC infliximab franchise nears halfway mark toward ₩1tri. won sales target Korea Biomedical Review 02:51 Thu, 27 Aug

Celltrion Expands Omlyclo® Portfolio in Europe with Launch of 300 mg Strength Business Wire (Press Release) 23:43 Mon, 24 Aug

Advertisement

Advertisement

Celltrion files Keytruda biosimilar in Korea, eyes US, Europe next Korea Biomedical Review 06:06 Mon, 24 Aug

Celltrion expands Japan push with SteQeyma IV launch The Korea Herald 06:01 Fri, 21 Aug

Celltrion launches Steqeyma IV in Japan, adds Crohn’s disease indication Korea Biomedical Review 03:42 Fri, 21 Aug

Celltrion expands Asia presence as key products retain market lead Korea Biomedical Review 02:48 Wed, 19 Aug

Celltrion eyes Europe-wide pharmacy sales after integrating France’s Gifrer Korea Biomedical Review 09:14 Tue, 18 Aug

Celltrion set to ramp up pharmacy biz in France with Gifrer acquisition The Korea Times 03:13 Tue, 18 Aug

Spotlight On: Biosimilar Litigations - August 2026 JD Supra 22:50 Mon, 17 Aug

Spotlight On: Rituxan® (rituximab) / Truxima® (rituximab-abbs) / Ruxience® (rituximab-pvvr) / Riabni™ (rituximab-arrx) - August... JD Supra 21:17 Mon, 17 Aug

Spotlight On: Herceptin® (trastuzumab) / Ogivri® (trastuzumab-dkst) / Herzuma® (trastuzumab-pkrb) / Ontruzant® (trastuzumab-dttb)... JD Supra 19:05 Mon, 17 Aug

Celltrion's Vegzelma tops 10% US market share as new analysis backs comparability Korea Biomedical Review 05:04 Fri, 14 Aug

Celltrion’s CT-P73 wins FDA Fast Track status for cervical cancer Korea Biomedical Review 02:17 Thu, 13 Aug

Celltrion’s Xolair biosimilar grabs over 90% of Spain’s omalizumab market Korea Biomedical Review 02:56 Wed, 12 Aug

Advertisement

Advertisement

About our Celltrion news

Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna